Private label cases/Product development
Your product – our know-how
Our research and development focus on tetrapodal zinc oxide (Microbivac®) that can form the basis for a wide range of pharmaceutical and cosmetic products.
Manufacturers can use this innovative active ingredient to develop their own customized products or to expand existing offerings with a white label solution. Our goal is to provide partners with the flexibility they need to be successful in the market.
Interested?
Individual White Label Solution
Open new market opportunities with a hydrogel formulation that is specifically tailored to the needs of your customers. Benefit from our expertise and ensure that you are always one step ahead of your competition.
With customized design and target group-specific claims, we help you to create a product that stands out and offers real added value.
Strong partnerships
As your partner in product development, we focus on close collaboration to ensure that the final product exceeds your expectations. From the initial idea to the market launch, we support you with tailor-made solutions and a strong brand that creates trust and strengthens loyalty.
Let’s work together to develop products that inspire and are successful.
Cooperation with KES Pharma
The company KES Pharma GmbH has developed an innovative acne serum in cooperation with Phi-Stone AG. The serum is based on the use of tetrapodal zinc oxide and shows promising properties in the fight against acne.
Tetrapodal zinc oxide is characterized by its unique structure and its excellent antimicrobial and anti-inflammatory properties. This compound can therefore not only help to improve the appearance of acne skin, but also helps to soothe the skin and reduce redness.
The cooperation with KES Pharma brings together bundled know-how and state-of-the-art technologies. KES Pharma is known for its expertise in the formulation and manufacture of cosmetic skincare products, while we bring extensive research experience in the field of dermatological applications.
Together with KES Pharma, we aim to develop further products to be marketed in the Asian region.
Successful cooperation with Liyfe Ltd
Liyfe and Phi-Stone have successfully concluded a distribution agreement whereby Liyfe will distribute the product under its own brand Skyn-V-Gel. This collaboration is a significant step in our global expansion and our commitment to provide customized solutions for different markets.
Sky-V for the MENA-Region was launched during Arab Health 2024. Liyfe has adapted the design, packaging, leaflet and promotional material for Skyn-V to meet the regulatory requirements in the MENA region as well as the multilingual and multicultural mix of consumers in these markets.
The launch of Skyn-V is an important milestone in our strategy to provide innovative solutions on a global scale. We are confident that this collaboration with Liyfe Ltd will help us to further expand our presence in the MENA region and deliver high quality, trustworthy products to consumers there.